Case Note: Anti-Competitive Pharmaceutical Strategies
In this case the Federal Court held that Pfizer was not engaging in anti-competitive behaviour by taking actions to protect its market position.
Competition
In this case the Federal Court held that Pfizer was not engaging in anti-competitive behaviour by taking actions to protect its market position.